NCT04618146

Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine.

Enhanced Recovery After Cesarean Section With Low Dose Intrathecal Morphine. A Prospective Randomized Controlled Study.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Minia University · Academic / Other
• Sex: Female
• Age: 16 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to see the effect of low dose intrathecal morphine on promting enhanced recovery after cesarean delivery with early ambulation and reduction of hospital stay.

Detailed description

Parturients showing for elective cesarean section will be randomized into 3 groups by a computer generated randomization list. Each randomization slip will be put in a sealed envelope until patient enrollment. Patients will be divided into Group C: control group, given intrathecal bupivacaine 12.5 mg. Group M25: intrathecal bupivacaine 12.5mg + morphine 25 microgram. Group M50: intrathecal bupivacaine 12.5mg + morphine 50 microgram.

Conditions

• Pain, Postoperative
• Pruritus
• Nausea, Postoperative
• Vomiting, Postoperative

Interventions

Type	Name	Description
DRUG	Morphine Sulfate	intrathecal low dose morphine for early return to normal activity without opioid related complications.
DRUG	Bupivacaine Hydrochloride	intrathecal bupivacaine 0.5%

Timeline

• Start date: 2020-11-10
• Primary completion: 2021-03-01
• Completion: 2021-03-01
• First posted: 2020-11-05
• Last updated: 2021-03-01

Locations

1 site across 1 country: Egypt